Startups
RNatives
RNatives develops investigational RNA medicines that regulate gene expression to address serious diseases. Its RNAIntel platform uses artificial intelligence, machine learning and genomic datasets to find small non-coding RNAs that can activate or silence genes, then validates selected candidates in laboratory experiments. The Finnish biotechnology company is developing precision therapies for ocular and metabolic diseases and cancer, with earlier published work also discussing cardiovascular and central nervous system applications. The underlying research uses RNA interactions to induce epigenetic changes that can have lasting effects on gene expression.
Founded 2020